Ventrix
Ventrix Bio Science Product Contact
Ventrix BioScienceProductContact
Ventrix
Ventrix Initiates Clinical Trial of VentriGel™

Ventrix, Inc., today announced that it has initiated a Phase 1 trial of VentriGel™, an off-the-shelf, biomaterial scaffold designed to facilitate the repair of cardiac tissue following myocardial infarction (MI), commonly known as a heart attack.

Adam KinseySeptember 17, 2015
Facebook0 Twitter 0 Likes
Next

Engineering a New Biomaterial Therapy for Treating Heart Attacks

Adam KinseyApril 7, 2014
Ventrix
3030 Bunker Hill Street,
San Diego, CA, 92109,
United States
6197860350 server@ventrixheart.com
Home

copyright 2017 - Ventrix, Inc.